338 active trials 181 recruiting 18 Phase 3 45 disease areas 10 changes in 30 days
8 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 7 with minor changes only.
Primary completion pushed from Mar 31, 2027 to Sep 30, 2029
Also in this update: Primary endpoint(s) modified; Completion pushed from Jul 31, 2027 to Sep 30, 2029
Ruijin HospitalPhase 4 NCT06468709 Registry history of NCT06468709 on ClinicalTrials.gov (opens the registry)
Updated
Sponsor refiled this as recruiting (was completed)
Ruijin HospitalNot specified NCT07366541 Registry history of NCT07366541 on ClinicalTrials.gov (opens the registry)
Updated
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
Ruijin HospitalNot applicable NCT06891326 Registry history of NCT06891326 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Not Yet Recruiting
Ruijin HospitalNot specified NCT06634732 Registry history of NCT06634732 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
Ruijin HospitalNot specified NCT06608160 Registry history of NCT06608160 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Nov 2023); last known: Recruiting
Ruijin HospitalNot applicable NCT05557552 Registry history of NCT05557552 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Jul 2022); last known: Not Yet Recruiting
Ruijin HospitalNot applicable NCT05485025 Registry history of NCT05485025 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Jul 2022); last known: Not Yet Recruiting
Ruijin HospitalNot applicable NCT05310890 Registry history of NCT05310890 on ClinicalTrials.gov (opens the registry)
Changed
Registry verification sweep
Changed
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-10-09 | NCT07867392 Neoadjuvant Iparomlimab and Tuvonralimab With Nab-P-SOX in Locally Advanced Gastric or… | Phase 2 | Recruiting |
| 2026-10-09 | NCT07868692 Fasciotomy and Predilation for Radial Artery Grafts in CABG | Not Yet Recruiting | |
| 2026-10-07 | NCT07862075 Inebilizumab for the Treatment of Patients With Type 1 Autoimmune Pancreatitis | Phase 4 | Recruiting |
| 2026-09-24 | NCT07838714 Dual-Targeted Umbilical Cord Blood CAR-T Cells Against CD19 and CD22 for the Treatment of… | Phase 1 | Recruiting |
| 2026-09-22 | NCT07834671 Research on Respiratory Support Decision-Making for Mechanically Ventilated ICU Patients… | Not Yet Recruiting | |
| 2026-09-17 | NCT07824479 Predicting Efficacy of Preoperative Immunotherapy in Advanced Gastric Cancer | Recruiting | |
| 2026-09-17 | NCT07824492 Transcutaneous Regulation for Atrial Prevention in Postoperative Atrial Fibrillation… | Not Yet Recruiting | |
| 2026-09-14 | NCT07819175 Pulsed Field Ablation for the Treatment of Persistent Atrial Fibrillation: Pulmonary Vein… | Not Yet Recruiting |
| Early Phase 1 | 15 | |
| Phase 1 | 18 | |
| Phase 1/2 | 14 | |
| Phase 2 | 88 | |
| Phase 2/3 | 2 | |
| Phase 3 | 16 | |
| Phase 4 | 7 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 4 | ||||
| NCT07862075 | Inebilizumab for the Treatment of Patients With Type 1 Autoimmune Pancreatitis | Type 1 AIP | Recruiting | 2026-10-07 |
| NCT06468709 | A Trial on the Remission Rates of Type I Autoimmune Pancreatits With High-risk of… | Type 1 AIP | Recruiting | 2026-10-06 |
| NCT06802926 | Pilot Trial of Colchicine for Graft Failure in CABG | CABG | Recruiting | 2026-09-02 |
| NCT06818084 | TRanscAtheter TreatMent of PurE Aortic Regurgitation With VitaFlow Liberty System | AORTIC VALVE DISEASES | Recruiting | 2026-01-30 |
| NCT05806580 | Secondary Infusion of Relma-cel Injection for Relapsed or Refractory B-cell Lymphoma | Relapsed or Refractory B-cell Lymphoma | Recruiting | 2024-10-23 |
| NCT07558811 | Effects of Glucocorticoid Therapy on Renal Function in Patients With PA Complicated by… | Primary Aldosteronism Due to Adrenal Hyperplasia | Not Yet Recruiting | 2026-04-30 |
| NCT07034222 | 12-Month Real-World Safety & Efficacy of Lecanemab in Early Alzheimer's Disease | Alzheimer's Disease(AD) | Active, Not Recruiting | 2025-06-24 |
| Phase 3 | ||||
| NCT05277688 | Adjuvant Concurrent Chemoradiotherapy Versus Radiotherapy in Early-stage Cervical Cancer… | Cervical Cancer | Recruiting | 2026-08-18 |
| NCT07229547 | A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study to… | Influenza | Recruiting | 2026-07-15 |
| NCT05018520 | The Safety and Effectiveness of 4R-CHOP+4R vs 6R-CHOP+2R in Newly Diagnosed Patients With… | Diffuse Large B Cell Lymphoma | Recruiting | 2026-05-11 |
| NCT07511127 | Comparing the Efficacy of Different Durations of Maribavir Treatment Regimens in Allo-HSCT | Hematologic Malignancy | Recruiting | 2026-04-06 |
| NCT07366528 | Adjuvant Oxaliplatin Plus S-1 Versus Docetaxel Plus S-1 for Stage III Gastric Cancer | Gastric Cancer (GC) | Recruiting | 2026-01-26 |
| NCT06522555 | The Efficacy and Safety of Pola-ZR2 Versus ZR2 in the Treatment of Old Patients With de… | Diffuse Large B-Cell Lymphoma | Recruiting | 2024-08-05 |
| NCT06496308 | Bendamustine and Rituximab With or Without Orelabrutinib in MCL Treatment | Mantle Cell Lymphoma (MCL) | Recruiting | 2024-07-11 |
| NCT06339060 | An Organ Preservation Strategies After Chemoradiotherapy Combined With Immunotherapy for… | Esophageal Cancer | Recruiting | 2024-07-03 |
| NCT03829553 | Hypofractionated Irradiation At Regional Nodal Area for Breast Cancer Vs Existed Standard… | Breast Cancer | Recruiting | 2022-06-02 |
| NCT07735117 | Mitoxantrone Hydrochloride Liposome, Cytarabine, G-CSF Plus Venetoclax vs. Azacitidine… | Acute Myeloid Leukemia (AML) | Not Yet Recruiting | 2026-07-29 |
| NCT07719855 | A Multicenter, Prospective, Open-Label, Randomized Controlled Clinical Study of… | Follicular Lymphoma ( FL) | Not Yet Recruiting | 2026-07-22 |
| NCT07511114 | A Study Comparing C Pola R-CHP+X With CR-CHOP in the Treatment of Previously Untreated… | DLBCL - Diffuse Large B Cell Lymphoma | Not Yet Recruiting | 2026-04-06 |
| NCT06449586 | CMV-specific T Cell Immunity Test Indicated Prophylaxis of Letermovir After All-HSCT | Hematologic Malignancy | Active, Not Recruiting | 2025-12-15 |
| NCT06297772 | Compare the Efficacy and Safety of Dec-FB4 and FB4 as Conditioning Regimen for AML-MR | AML, Adult | Not Yet Recruiting | 2024-06-04 |
| NCT06255795 | The Efficacy and Safety of Chidamide, Anti-PD-1 Antibody in Combination With Pegaspargase… | Extranodal Natural Killer T Cell Lymphoma | Not Yet Recruiting | 2024-02-13 |
| NCT04384601 | Dragon III-Phase 3: Neoadjuvant Chemotherapy (FLOT Versus SOX) for Gastric Cancer | Gastric Cancer | Not Yet Recruiting | 2021-07-19 |
| Phase 2/3 | ||||
| NCT06972641 | Molecular Genetics Guide the Maintenance Therapy After Allogeneic Hematopoietic Stem Cell… | AML | Recruiting | 2025-05-18 |
| NCT04208347 | Perioperative Treatment of Combined SOX With Apatinib and Camrelizumab for… | Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma | Active, Not Recruiting | 2026-01-23 |
Non-Hodgkin Lymphoma (52) · DLBCL (33) · Leukemia (19) · Pancreatic Cancer (19) · Acute Myeloid Leukemia (AML) (13) · Breast Cancer (13) · Gastric Cancer (13) · Parkinson's Disease (11) · Colorectal Cancer (9) · Lung Cancer (9)